Britanica · Growing years
Portfolio preview · Concept
BriMag Kids
Pediatric magnesium development concept
A growing-years development concept exploring magnesium and vitamin B6. Final formulation and dosage form are pending.
Development concept · Final formula and dosage form pending. Artwork is illustrative.
This is a development presentation, not a launched product or a supply commitment.
Life, in perspective
Their world. Our consideration.
A development story built around clarity and care. The reference formula and original presentation are a starting point for QA and regulatory review—not an approved recommendation for children.
A considered formula
The reference formula.
Ingredients from the reference concept only. Final composition, quantities, age range and permitted claims require QA and regulatory approval before launch.
Magnesium
50 mg appears in the development brief; no per-drop, per-mL or daily-dose basis is established.
Vitamin B6
1 mg appears in the development brief; the serving basis is not established.
Temporary development reference · No serving basis established · Not dosing instructions
Product information
The detail behind the product.
From the ingredient identity to the technical documentation pathway, start with clear product-specific information.
About this formula
BriMag Kids is a pediatric magnesium development concept. The temporary brief mentions magnesium bisglycinate and vitamin B6; it is not an approved Britanica formula. Final composition, dosage form, serving basis, age range and directions are pending. Reference quantities and artwork must not be interpreted as a child’s dose.
Directions & suitability
Final directions, dosage, minimum age and suitability have not been confirmed. This reference presentation must not be used as dosing advice. Britanica QA and the relevant regulatory team will confirm the approved information before launch.
Formula & specifications
The ingredients and quantities shown here are a reference formula, not an approved finished-product specification. Final formulation, dosage, permitted claims and market availability remain subject to QA and regulatory confirmation.
Packaging & market availability
Final dosage form and pack size are pending. This concept artwork does not establish an approved drop presentation, tablet presentation or bottle volume.
Quality & regulatory documentation
Product licences, manufacturing origin, certificates and registration requirements are confirmed product by product. Controlled technical documents are shared with qualified partners through Britanica QA under appropriate confidentiality arrangements.
Private partner dialogue
Explore the concept with us.
Discuss the development brief and your market requirements with Britanica. A conversation does not confirm formulation, approval, launch timing or supply.
Discuss This Concept
Draft concept · Final formula, directions, age range, permitted claims and availability are subject to QA and regulatory confirmation.
Return to the portfolio